Risk of morbidity and mortality in patients with type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor and/or dipeptidyl peptidase-4 inhibitor: a nationwide study

Absztrakt
Leírás
Kulcsszavak
Forrás
BMJ Open Diabetes Research & Care. -9 : 1 (2021), p. 1-10. -BMJ Open Diab Res Care. - 2052-4897